F32.9: A Therapist's Reference for Major Depressive Disorder, Unspecified
Outline
Major depressive disorder, single episode, unspecified is one of the most-billed codes in outpatient mental health, and it is also the diagnostic pick that most often draws audit questions. The clinical reality is straightforward: at intake, a clinician can usually establish that a client meets MDD criteria within the first session or two, but assigning a specific severity specifier (mild, moderate, moderate-severe, severe without psychotic features, severe with psychotic features) requires either a validated severity measure or a clearer view of functional impairment than a single session typically supplies. The unspecified code holds the diagnosis in place until the severity question can be answered with confidence.
The audit risk concentrates exactly where the clinical convenience is. A chart that carries this code indefinitely, never resolving to one of the severity-specified codes, is the documentation pattern most often flagged in payer reviews and licensing-board audits. The unspecified pick is appropriate at intake; it is not appropriate as a permanent placeholder. What separates a defensible chart from a vulnerable one is the visible plan to revisit the severity specifier within the first three to four sessions and recode when the PHQ-9 trajectory and clinical picture support a specific severity call.
For licensed therapists, psychologists, counselors, and clinical social workers who diagnose and bill under ICD-10-CM, this page is part of the ICD-10 codes for therapists sub-hub. The DSM-5 criteria, the F32 severity-specifier family, the F33 recurrence question, the F34.1 persistent depressive disorder differential, the F43.21 adjustment-disorder differential, the audit-ready documentation pattern, and the CPT pairings each get their own section below.
Educational reference for licensed mental health practitioners. Coding and documentation requirements vary by state, payer, and setting; verify against your state licensing board, payer contracts, and the current ICD-10-CM official guidelines for the year of service.
What f32.9 means in ICD-10-CM
ICD-10-CM defines f32.9 as “Major depressive disorder, single episode, unspecified.” The code sits inside the F30-F39 parent block (mood [affective] disorders). Inside that block, F32 is the category for “Major depressive disorder, single episode,” and the fifth-character specifier identifies severity, remission status, or unspecified. F33 is the parallel category for recurrent episodes; the choice between F32 and F33 turns on whether the current episode is the first one the client has experienced or a subsequent episode following at least one prior major depressive episode separated by at least two consecutive months in which criteria were not met.
The unspecified specifier under F32 is appropriate when the diagnostic criteria for a major depressive episode are met but the severity cannot yet be specified, or when the picture does not align cleanly with one of the specified severity descriptors. The official descriptor is published by the Centers for Medicare and Medicaid Services and mirrored at icd10data.com, with the broader CMS reference at the CMS ICD-10 page. The DSM-5 itself, published by the American Psychiatric Association, aligns the diagnostic criteria with the ICD code, although the ICD descriptor is what payers expect to see on the claim line. Use the descriptor wording as published; reviewers expect the specifier language to match the official text rather than a paraphrase.
DSM-5 criteria for a major depressive episode
The DSM-5 criteria for a major depressive episode are five lettered criteria that together establish the diagnosis. The summary table is intended for quick chart-side reference; the full descriptors live in the DSM-5 itself.
| Criterion | What it requires | Threshold for the chart |
|---|---|---|
| A: Symptom count | Five or more of nine symptoms present during the same two-week period and representing a change from previous functioning; at least one is either (1) depressed mood or (2) loss of interest or pleasure. The nine symptoms are: depressed mood, anhedonia, weight or appetite change, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue or loss of energy, worthlessness or excessive guilt, concentration or decision-making difficulty, recurrent thoughts of death or suicidal ideation. | Document at least five symptoms with concrete client report or observation; identify which symptom serves as the anchor (depressed mood or anhedonia). |
| B: Clinical significance | Symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. | Concrete impacts on work, relationships, sleep, role function, or self-care. |
| C: Differential (substance/medical) | The episode is not attributable to the physiological effects of a substance or another medical condition. | Substance use, medication side-effects, hypothyroidism, anemia, and other medical contributors considered and ruled out or referred for ruleout. |
| D: Differential (psychotic spectrum) | The episode is not better explained by schizoaffective disorder and is not superimposed on schizophrenia, schizophreniform disorder, delusional disorder, or other psychotic-spectrum disorders. | Psychotic spectrum considered and ruled out. |
| E: No mania or hypomania | There has never been a manic episode or a hypomanic episode. | Bipolar history screened for and documented as negative. |
The two-week duration test in Criterion A is the gateway. A presentation that meets the symptom-count and impairment thresholds but has not yet reached two weeks does not meet MDD criteria; the right code at that point is either the unspecified single-episode code with the chart making clear the criterion is anticipated to be met at re-assessment, or an adjustment disorder code if the picture is genuinely stressor-anchored and time-limited.
Specifiers that attach when applicable include with anxious distress, with mixed features, with melancholic features, with atypical features, with mood-congruent or mood-incongruent psychotic features, with catatonia, with peripartum onset, and with seasonal pattern. The severity specifier (mild, moderate, moderate-severe, severe without psychotic features, severe with psychotic features) is what drives the fifth-character ICD code under F32; the descriptive specifiers above are documented in the formulation rather than embedded in the ICD code.
When this code is the right pick over a severity-specified F32 code
The choice between the unspecified code and the severity-specified F32 codes turns on what the chart can support. The severity codes carry distinct fifth-character meaning, and the unspecified pick is appropriate only when the chart genuinely cannot yet support a more specific call.
| Code | Specifier | When to use |
|---|---|---|
| F32.0 | Mild | Few symptoms in excess of the five required for diagnosis, minor impairment in role function. PHQ-9 typically 5 to 9. |
| F32.1 | Moderate | Number of symptoms, intensity of symptoms, or functional impairment between mild and severe. PHQ-9 typically 10 to 14. |
| F32.2 | Moderate-severe (severe without psychotic features) | Number of symptoms substantially in excess of those required, intensity seriously distressing, marked interference with social and occupational functioning. PHQ-9 typically 15 to 19. (In DSM-5 terms, often categorized as “severe.”) |
| F32.3 | Severe with psychotic features | Severe presentation plus delusions or hallucinations, typically mood-congruent. Refer for medication management and document the psychotic-features specifier. |
| F32.4 | In partial remission | Symptoms of the immediately previous major depressive episode are present but full criteria are no longer met, or there has been a period lasting less than two months without any significant symptoms following the end of the episode. |
| F32.5 | In full remission | During the past two months no significant signs or symptoms of the disturbance were present. |
| F32.81 | Premenstrual dysphoric disorder | Distinct condition; documented separately. |
| F32.89 | Other depressive episodes | Used for presentations that meet MDE criteria but do not align with a severity specifier, including some atypical or melancholic features that complicate severity rating. |
| f32.9 | Single episode, unspecified | Diagnostic criteria met, severity not yet established or genuinely not classifiable into a specified subtype. Appropriate at intake; not appropriate as a long-term carry. |
The PHQ-9 (Patient Health Questionnaire-9) is the validated measure most commonly used to inform the severity specifier. Score ranges of 5 to 9 (mild), 10 to 14 (moderate), 15 to 19 (moderate-severe), and 20 or above (severe) align reasonably with the F32.0 through F32.2 severity descriptors. A chart that documents a PHQ-9 score at intake and at session-three or session-four re-evaluation creates the kind of repeatable measurement that an auditor can read at a glance and that supports the recode from the unspecified code to a severity-specified F32 code.
The audit-defensive pattern is to use this code only at intake and only when the chart explicitly states that severity will be assessed and the specifier updated within the first three to four sessions. A chart that codes the unspecified specifier at intake and continues with it across ten or twenty sessions without ever resolving to a severity specifier is reading, to an auditor, as a clinician who never completed the diagnostic work.
F32 (single episode) versus F33 (recurrent)
The F32 family applies to a single major depressive episode; F33 applies when the current episode is preceded by at least one prior major depressive episode, with the two episodes separated by at least two consecutive months in which criteria for a major depressive episode were not met. The decision rule is straightforward in principle and frequently underdocumented in practice.
| Code | Condition | When to use |
|---|---|---|
| F32.x | MDD, single episode | The current episode is the client’s first major depressive episode, or the chart cannot establish a prior episode. |
| F33.x | MDD, recurrent | The current episode is a subsequent episode following at least one prior major depressive episode separated by at least two consecutive months in which criteria were not met. Severity specifiers (F33.0 mild through F33.3 severe with psychotic features) parallel the F32 severity specifiers. |
| F33.4x | MDD, recurrent, in remission | Either partial (F33.41) or full (F33.42) remission. |
| F33.9 | MDD, recurrent, unspecified | Recurrent episode with severity not yet established. |
When a client describes a clear prior major depressive episode in the history (often during high school, college, after a previous relationship ending, or after a prior medical event), the current episode is the second episode and the chart should code F33 rather than F32 from the start. When the prior-episode history is unclear at intake (the client describes “some low periods” without enough detail to establish whether they met MDD criteria), the chart can reasonably begin with F32 while flagging the recurrent question for clarification in subsequent sessions, then recode to F33 if the history declares a prior episode that met MDD criteria.
The chart’s handling of the prior-episode question is what auditors look at first when they see the unspecified single-episode code on a client whose age and presentation suggest a likely prior episode. A one-line note that the history was screened for prior episodes and the current episode is the first identified is the kind of brief discipline that closes the audit objection.
Differential: f32.9 versus persistent depressive disorder (F34.1)
Persistent depressive disorder (formerly dysthymia) is the chronic mood-disorder differential most often confused with MDD. F34.1 requires a depressed mood for most of the day, for more days than not, for at least two years in adults (one year in children and adolescents), with at least two of six accessory symptoms (poor appetite or overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor concentration or indecisiveness, feelings of hopelessness). The symptom count is lower than MDD and the duration is much longer.
The decision rule turns on chronicity and symptom count. A client who has experienced depressed mood for the past two years or longer with two or three accessory symptoms but never met full MDD criteria is in the F34.1 lane. A client who has experienced a discrete episode of full MDD criteria for the past several weeks to several months without a chronic two-year history is in the F32 lane. A client who has a chronic two-year history of low-grade depression with a superimposed acute MDD episode meets both diagnoses and may be coded as “double depression” with both codes on the claim, although coding conventions for combined F32/F34.1 vary by payer.
A chart that codes the unspecified MDD code on a client who endorses a chronic multi-year low-mood history without screening for the F34.1 differential leaves the most common chronic-depression audit objection unanswered. The fix is a brief note in the assessment that names the chronicity question and rules F34.1 in or out based on the duration test.
Differential: this code versus adjustment disorder with depressed mood (F43.21)
The other common differential is between this code and F43.21, adjustment disorder with depressed mood. The decision rule is straightforward in principle and underdocumented in practice. F32.x or F33.x is the right code when the symptom count, duration, and severity meet MDD criteria, regardless of whether a stressor is present. The presence of a stressor does not downgrade MDD to an adjustment disorder.
| Scenario | Right code | Why |
|---|---|---|
| Low mood follows a clear stressor, fewer than 5 of 9 MDD symptoms, duration shorter than the MDD two-week minimum, no functional collapse | F43.21 | Symptom count and severity below MDD threshold. For the documentation specifics, see the F43.21 adjustment disorder with depressed mood guide. |
| Low mood follows a clear stressor, but client meets 5+ MDD symptoms for at least two weeks with marked impairment | f32.9 (then recode to severity) | Full MDD criteria met. Stressor is contextual but does not change the diagnosis. |
| Picture is unclear at intake regarding subtype within the adjustment-disorder family | F43.20 | Adjustment-disorder criteria met but the predominant subtype not yet clear. For the documentation specifics, see the F43.20 unspecified adjustment disorder guide. |
| Chronic low-grade depressed mood for more than two years without ever reaching full MDD criteria | F34.1 | Persistent depressive disorder; chronicity exceeds the adjustment-disorder window and the MDD episode threshold. |
A one-line note in the assessment that names the MDD criteria the client DOES meet (the specific five-of-nine count, the two-week duration, the functional impairment) is the single highest-value sentence to write to defend the unspecified MDD code over F43.21. “Client meets MDD criteria: depressed mood, anhedonia, fatigue, concentration difficulty, sleep disturbance, and worthlessness present continuously for the past four weeks with marked occupational impairment; the recent job termination is the proximate stressor but the symptom count and duration meet MDE threshold independent of the stressor.” That sentence closes off the most common audit objection in advance.
Documentation that holds up under audit
A defensible MDD-unspecified chart establishes six elements at intake and revisits them in subsequent sessions until the severity specifier resolves.
- The full MDD criterion set documented with concrete client report. The chart should make the symptom count visible: which of the nine symptoms are present, with supporting evidence from session content. Generic language (“client endorses depressive symptoms”) is weaker than specific report (“client endorses daily depressed mood for the past five weeks, complete loss of interest in previously enjoyed activities including running and cooking, sleep onset insomnia averaging two hours nightly, fatigue interfering with morning work routine, hourly intrusive thoughts of worthlessness, and concentration difficulty preventing completion of work tasks”).
- The two-week duration test established. The chart should make clear that symptoms have been present continuously for at least two weeks. A note that documents onset date and current duration closes the Criterion A timeline.
- The severity question explicitly flagged for resolution. The intake note should state that severity will be assessed via PHQ-9 and clinical judgment, and that the diagnosis will be recoded to F32.0 through F32.2 (or F32.3 if psychotic features emerge) at session-three or session-four re-evaluation.
- Differential closed off in writing. A brief note that the chart has considered F33 (no prior MDE identified, or prior MDE identified and the chart will recode to F33), F34.1 (no chronic two-year low-mood history, or such history identified and ruled in), and F43.21 (the symptom count and duration meet MDE criteria independent of any stressor) closes the most common differential objections in advance.
- Suicidality assessment documented. Criterion A includes recurrent thoughts of death or suicidal ideation, and the chart should document the suicide risk assessment explicitly: ideation, plan, intent, means, history, protective factors, and the safety planning conducted if indicated. This is the highest-stakes element on any MDD chart and the one that licensing boards scrutinize first.
- Treatment plan tied to MDD with a planned re-evaluation point. The plan should target symptom reduction with measurable outcomes (PHQ-9 trajectory, return-to-work goals, sleep restoration) and identify the session number at which the diagnosis will be revisited. A plan that says “diagnosis will be re-evaluated at session four; severity specifier will be assigned based on PHQ-9 trajectory and functional impairment” is exactly the pattern auditors read favorably.
Measurement-based care strengthens the chart further. The PHQ-9 administered at intake, session three or four, and then on a four-to-six-week cadence creates a repeatable measurement that signals the clinician is tracking the trajectory rather than carrying an unspecified code by inertia. For the broader implementation pattern, the measurement-based care practical guide for therapists covers the cadence and chart-integration approach. The PHQ-9 is the most widely recognized and payer-accepted depression severity measure; alternative instruments (BDI-II, HAM-D, QIDS) are also acceptable, but PHQ-9 is what most commercial payers and Medicare quality programs expect to see.
The American Psychological Association’s record-keeping guidance and the HIPAA provisions at 45 CFR § 164.501 distinguish between psychotherapy notes, which are kept separate and receive heightened protection, and the progress notes that go into the medical record. Diagnostic justification belongs in the progress note and the treatment plan, not in psychotherapy notes, because the progress note is what supports the billed diagnosis under audit.
Clinical use in therapy
In outpatient practice, this code at intake commonly applies to clients presenting with a clear MDD picture where severity has not yet been established with a validated measure. The presentation often includes depressed mood lasting several weeks, anhedonia, sleep disturbance, fatigue, concentration difficulty, and either worthlessness or recurrent thoughts of death. The client may or may not be able to identify a precipitating event; many MDD episodes occur without a clear external trigger, and the absence of a stressor does not weaken the diagnosis.
Modality fit follows from the clinical picture. Cognitive behavioral therapy is the modality with the strongest evidence base for MDD and is the default in most outpatient practices. Behavioral activation is a tightly evidence-based treatment that targets anhedonia and withdrawal directly. Interpersonal therapy fits clients whose depression is anchored in role transitions, role disputes, grief, or interpersonal deficits. Acceptance and commitment therapy can fit clients whose depression centers on values disruption and existential meaning-making. For clients with moderate-severe or severe presentations, the treatment plan should typically include a referral for medication evaluation alongside psychotherapy; the chart should document the referral and the rationale.
CPT codes commonly paired with this code
The diagnostic code identifies the condition; the procedure code identifies the service rendered. The CPT codes most commonly paired with this diagnosis are 90791 for the diagnostic evaluation at intake (no medical services), 90832 for psychotherapy of approximately 30 minutes, 90834 for approximately 45 minutes (the most common routine code in outpatient practice), and 90837 for approximately 60 minutes. Add-on code 90785 for interactive complexity may apply when communication factors complicate the session. For the new-patient evaluation code that prescribers pair with the same diagnosis, see the 99204 new patient evaluation guide.
| CPT code | Service | When it fits the chart |
|---|---|---|
| 90791 | Psychiatric diagnostic evaluation (no medical services) | The intake encounter where the diagnosis is established. |
| 90832 | Psychotherapy, ~30 minutes | Brief follow-up session, often used in measurement-based-care check-ins. |
| 90834 | Psychotherapy, ~45 minutes | The most common routine code for ongoing weekly therapy. |
| 90837 | Psychotherapy, ~60 minutes | When session content and time documentation support the longer band; often used for trauma-informed or grief-focused depression work. |
| 90785 | Interactive complexity add-on | When communication factors complicate the session. |
| 99204 | New patient evaluation (E/M, prescribers only) | When a prescriber on staff conducts the new-patient evaluation. |
The diagnostic and procedure codes travel together on the claim line. This code should appear as the primary diagnosis pointer on each psychotherapy CPT line during the active treatment episode while the severity question is open. Once the recode to F32.0 through F32.2 is made, the new specifier replaces it on subsequent claim lines. Time-based CPT codes require time documentation in the note that supports the code billed; payers routinely deny 90837 when the note does not establish that the session ran to the time threshold.
Common errors that draw audit attention
Three patterns recur in MDD-unspecified charts that fail review, and each is preventable at intake.
The first is the indefinite carry. A chart that codes this specifier at intake and continues with the same code across ten or twenty sessions without ever resolving to a severity specifier is reading, to an auditor, as a clinician who never completed the diagnostic work. The fix is the planned re-evaluation point in the treatment plan, the PHQ-9 trajectory captured in the chart, and the actual recode to F32.0 through F32.2 at session three or four.
The second is the missing recurrence screen. A chart that codes the unspecified MDD code on a client whose history includes prior depressive episodes that meet MDD criteria should be coded F33, not F32. The fix is a one-line screen for prior MDEs in the intake assessment, with the chart’s reasoning visible if the current episode is coded as the first identified.
The third is the missing suicidality documentation. MDD charts that do not document the suicide risk assessment explicitly fail the most basic licensing-board expectation. The fix is a structured risk assessment in the intake note (ideation, plan, intent, means, history, protective factors) and a documented safety plan if indicated.
How Emosapien handles f32.9 during the session
Emosapien’s Scribe Agent works alongside the clinician as an active co-therapist during intake and ongoing sessions. When the conversation establishes the MDD criterion set (the symptom count, the two-week duration, the functional impairment, the differential), the agent surfaces this code as a diagnostic candidate alongside the criteria checklist and a flag noting that the severity specifier should be revisited within the first three to four sessions. The clinician reviews the suggestion, accepts or revises it, and the Assessment section of the progress note populates with the criterion-by-criterion mapping, the symptom inventory, and the differential reasoning that supports the unspecified pick at intake.
When the PHQ-9 trajectory clarifies the severity picture, the agent flags the recode opportunity in the next note draft with the supporting evidence inline (the PHQ-9 score, the symptom changes, the functional-impairment update). The chart’s diagnostic trail shows the move to F32.0 through F32.2 with the supporting evidence visible to a chart reviewer, which is exactly the pattern auditors look for. This is not coding automation. The clinician makes the diagnosis. The agent surfaces the candidate, shows its work against the DSM-5 criteria and the ICD-10-CM descriptor, and produces an Assessment that is ready for chart review without retyping. See the AI clinical notes overview for how the Scribe Agent handles documentation across the rest of the note, or start a trial to see candidate diagnostic suggestions in your own intake workflow.